Symbia Intevo 6, SPECT/CT System, Emission Computed Tomography System To detect or image the dis...

FDA Device Recall #Z-0094-2018 — Class II — November 7, 2017

Recall Summary

Recall Number Z-0094-2018
Classification Class II — Moderate risk
Date Initiated November 7, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Siemens Medical Solutions USA, Inc.
Location Hoffman Estates, IL
Product Type Devices
Quantity 2 units

Product Description

Symbia Intevo 6, SPECT/CT System, Emission Computed Tomography System To detect or image the distribution of radionuclides in the body or organ, using the following techniques: planar imaging, whole body imaging, tomographic imaging for isotopes with energies up to 588keV. SPECT: To detect or image the distribution of radionuclides in the body or organ, using the following techniques: planar imaging, whole body imaging, tomographic imaging for isotopes with energies up to 588keV. CT: The CT component is intended to produce cross sectional images of the body by computer reconstruction of x-ray transmission data from either the same axial place taken at different angles or spiral planes taken at different angles.SPECT+CT: Perform CT scans and nuclear imaging studies within the same instrument. To obtain attenuation corrected images and to provide registration of anatomical and physiological images within the patient's anatomy. These systems are intended to be utilized by appropriately trained health care professionals to aid in detecting, localizing, diagnosing, staging and restaging of lesions, tumors, disease and organ function for the evaluation of diseases and disorders such as, but not limited to, cardiovascular disease, neurological disorders and cancer. The images produced by the system can also be used by the physician to aid in radiotherapy treatment planning and interventional radiology procedures.

Reason for Recall

The Broad Quantification option of the Symbia product software version VB20A may not allow modification of two data input values. The failure occurs when the system with the Broad Quantification option is calibrated with phantoms that do not have a volume of 6500ml and/or when residual dose needs to be entered.

Distribution Pattern

Worldwide Distribution to Malaysia, France, Japan, Reunion Island

Lot / Code Information

Serial Number: 2141, 2144

Other Recalls from Siemens Medical Solutions USA, Inc.

Recall # Classification Product Date
Z-3217-2024 Class II ACUSON Maple 1.0 Diagnostic Ultrasound System, ... Aug 15, 2024
Z-3215-2024 Class II ACUSON Juniper 1.0, 1.5, 2.0, 2.5 Diagnostic Ul... Aug 15, 2024
Z-3216-2024 Class II ACUSON Redwood 1.0 and 2.0 Diagnostic Ultrasoun... Aug 15, 2024
Z-1599-2024 Class II ACUSON Juniper Diagnostic Ultrasound System, RE... Feb 23, 2024
Z-1601-2024 Class II ACUSON Maple Diagnostic Ultrasound System, REF:... Feb 23, 2024

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.